BD PharmingenTM PerCP-CyTM5.5 Annexin V

Description

Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System. Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System. Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System. Staining cells with PerCP-Cy5.5 Annexin V and multicolor flow cytometric analysis of cells undergoing apoptosis. Jurkat T cells were left untreated Left Panel or treated for 4 hours Right Panel with 6 muM camptothecin. Cells were incubated with PerCP-Cy5.5 Annexin V Cat. No. 561431 and analyzed by flow cytometry. Untreated cells were primarily PerCP-Cy5.5 Annexin V negative, indicating that they were viable and not undergoing apoptosis Left Panel . After a 4 hour treatment with camptothecin, there were two populations of cells: cells undergoing apoptosis PerCP-Cy5.5 Annexin V positive , and cells that were viable and not undergoing apoptosis PerCP-Cy5.5 Annexin V negative Right Panel . Flow cytometry was performed using a BD LSR II Flow Cytometer System.